Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -488 | 30,831 | -15,803 | -28,533 | -74,270 |
| Depreciation Amortization | 22,418 | 11,130 | 1,201 | 9,782 | 9,748 |
| Accounts receivable | -19,242 | -37,322 | -2,306 | -8,809 | -1,813 |
| Other Working Capital | 19,874 | -88,987 | -14,006 | -29,522 | 11,034 |
| Other Operating Activity | 65,170 | 75,173 | -4,112 | 4,816 | -3,850 |
| Operating Cash Flow | $87,732 | $-9,175 | $-35,026 | $-52,266 | $-59,151 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,763 | 28,047 | -145,050 | -187,818 | 26,380 |
| PPE Investments | -89,801 | -56,368 | -22,413 | -24,583 | -6,486 |
| Net Acquisitions | -17,517 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -2,120 | -7,439 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 16,683 | 17,100 | 19,800 | 3,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 31,180 |
| Investing Cash Flow | $-79,675 | $-19,077 | $-150,363 | $-192,601 | $54,074 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -20,909 | 17,543 |
| Debt Issued | N/A | N/A | 316,350 | 166,979 | N/A |
| Debt Repayment | -185 | -94 | N/A | N/A | N/A |
| Common Stock Issued | 10,886 | 28,443 | 15,220 | 140,518 | 64,110 |
| Other Financing Activity | -74,487 | -5,540 | -7,000 | 9,349 | -51,566 |
| Financing Cash Flow | $-63,786 | $22,809 | $324,570 | $295,937 | $30,087 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 1 |
| Beginning Cash Position | 222,900 | 228,343 | 89,162 | 38,092 | 13,081 |
| End Cash Position | 167,171 | 222,900 | 228,343 | 89,162 | 38,092 |
| Net Cash Flow | $-55,729 | $-5,443 | $139,181 | $51,070 | $25,011 |
| Free Cash Flow | |||||
| Operating Cash Flow | 87,732 | -9,175 | -35,026 | -52,266 | -59,151 |
| Capital Expenditure | -89,801 | -56,368 | -22,413 | -24,583 | -6,486 |
| Free Cash Flow | -2,069 | -65,543 | -57,439 | -76,849 | -65,637 |